Huijberts, S. C. F. A., Boelens, M. C., Bernards, R., & Opdam, F. L. (2020). Mutational profiles associated with resistance in patients with BRAFV600E mutant colorectal cancer treated with cetuximab and encorafenib +/− binimetinib or alpelisib. Br J Cancer.
Styl ChicagoHuijberts, Sanne C. F. A., Mirjam C. Boelens, Rene Bernards, a Frans L. Opdam. "Mutational Profiles Associated With Resistance in Patients With BRAFV600E Mutant Colorectal Cancer Treated With Cetuximab and Encorafenib +/− Binimetinib or Alpelisib." Br J Cancer 2020.
Citace podle MLAHuijberts, Sanne C. F. A., Mirjam C. Boelens, Rene Bernards, a Frans L. Opdam. "Mutational Profiles Associated With Resistance in Patients With BRAFV600E Mutant Colorectal Cancer Treated With Cetuximab and Encorafenib +/− Binimetinib or Alpelisib." Br J Cancer 2020.